脑膜瘤颅内出血:2个新危险因素
本文报告一例56岁女性,因服用艾司西酞普兰及大剂量雌激素替代治疗,发生岩斜区脑膜瘤自发性蛛网膜下腔出血伴脑室内出血;病理确诊为世界卫生组织I级脑膜瘤。作者提出5-羟色胺调节治疗和大剂量雌激素替代治疗可能是脑膜瘤出血的两个新危险因素。
要点
- 脑膜瘤自发性出血罕见,已知危险因素包括年龄>70岁或<30岁、脑室内或凸面位置、恶性/纤维型/血管母细胞型组织病理、高血压、抗凝治疗及创伤性脑损伤。
- 本病例为56岁女性,服用艾司西酞普兰和大剂量雌激素替代治疗,发生岩斜区世界卫生组织I级脑膜瘤自发性蛛网膜下腔出血伴脑室内出血。
- 作者提出5-羟色胺调节治疗和大剂量雌激素替代治疗可能是脑膜瘤出血的新危险因素,需考虑。
核心结论
- 脑膜瘤自发性出血罕见;作者提出5-羟色胺调节治疗和大剂量雌激素替代治疗可能是脑膜瘤出血的两个新危险因素,需考虑。
研究设计与样本
- 病例报告:一例56岁女性世界卫生组织I级岩斜区脑膜瘤患者。
主要发现
- 患者因自发性蛛网膜下腔出血伴脑室内出血就诊,处于昏迷状态;病理确诊为世界卫生组织I级脑膜瘤。
- 术后患者神经功能恶化,出现基底动脉血管痉挛、癫痫发作、发热及新发心房颤动。
关键数值与推荐
- 已知危险因素:年龄>70岁或<30岁;脑室内或凸面位置;恶性、纤维型或血管母细胞型组织病理;高血压、抗凝治疗及创伤性脑损伤。
临床怎么用
- 作者提出5-羟色胺调节治疗和大剂量雌激素替代治疗可能是脑膜瘤出血的新危险因素,需考虑。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningiomas are the most common benign intracranial tumor. Although meningiomas are slow growing and potentially highly vascularized, hemorrhage of these tumors is rare. We propose 2 novel modifiable risk factors that may provoke intratumoral hemorrhage of a World Health Organization grade I meningioma. CASE DESCRIPTION: We outline the clinical presentation of a 56-year-old female with spontaneous subarachnoid hemorrhage with intraventricular extension in a coma from a petroclival meningioma taking escitalopram for depression and high-dose estrogen replacement therapy for menopause. Pathology confirmed the diagnosis of World Health Organization grade I meningioma. Postoperatively, the patient declined neurologically and developed vasospasm of the basilar artery, as well as seizures, fever, and new-onset atrial fibrillation. CONCLUSIONS: Spontaneous hemorrhage of meningiomas is a rare event. Known risk factors are age older than 70 or younger than 30; intraventricular or convexity location; malignant, fibrous, or angioblastic histopathology; and presence of hypertension, anticoagulation therapy, and traumatic brain injury. We propose 2 new risk factors to be considered that may predispose to hemorrhage of a meningioma: serotonin-modulating therapy and high-dose estrogen-replacement.
引用
- Pressman E, Penn D, Patel NJ, et al. Intracranial Hemorrhage from Meningioma: 2 Novel Risk Factors. World Neurosurg. 2019. PMID: 31698125. doi:10.1016/j.wneu.2019.10.173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。